HM PAYSON & CO - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
HM PAYSON & CO ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$12,207
+171.6%
789
+175.9%
0.00%
Q2 2023$4,494
-4.7%
2860.0%0.00%
Q1 2023$4,714
-22.7%
286
-26.9%
0.00%
Q4 2022$6,100
+52.5%
391
+36.7%
0.00%
Q3 2022$4,0000.0%2860.0%0.00%
Q2 2022$4,0000.0%2860.0%0.00%
Q1 2022$4,000
-71.4%
286
-72.3%
0.00%
Q4 2021$14,000
-17.6%
1,0310.0%0.00%
Q3 2021$17,0000.0%1,0310.0%0.00%
Q2 2021$17,000
-10.5%
1,031
-1.0%
0.00%
-100.0%
Q1 2021$19,0000.0%1,0410.0%0.00%0.0%
Q4 2020$19,0000.0%1,0410.0%0.00%0.0%
Q3 2020$19,0000.0%1,0410.0%0.00%0.0%
Q2 2020$19,000
+18.8%
1,0410.0%0.00%0.0%
Q1 2020$16,000
-36.0%
1,041
-19.4%
0.00%0.0%
Q4 2019$25,000
-55.4%
1,292
-60.5%
0.00%
-50.0%
Q3 2019$56,000
-30.0%
3,273
-27.4%
0.00%
-33.3%
Q2 2019$80,0004,5090.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders